The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
3 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $978,756 in first-year total cost, median $255,897.
Most frequent study sections
- Special Emphasis Panel[ZHL1 CSR-O (F1)]3
Most frequent institutions
- REGENERATIVE RESEARCH FOUNDATION1
- STEADMAN PHILIPPON RESEARCH INSTITUTE1
- UNIVERSITY OF ILLINOIS AT CHICAGO1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2020 | The Use of Senolytic and Anti-Fibrotic Agents to Improve the Beneficial Effect of Bone Marrow Stem Cells for Osteoarthritis1UG3AR077748-01 | HUARD, JOHNNYPHILIPPON, MARCTASHMAN, SCOTT | STEADMAN PHILIPPON RESEARCH INSTITUTE, CO | $522,288 | ZHL1 |
| 2020 | Phase I Study of Mesenchymal Stromal Cell Secretome for Promoting Corneal Regeneration1UG3EY031809-01 | DJALILIAN, ALI R | UNIVERSITY OF ILLINOIS AT CHICAGO, IL | $255,897 | ZHL1 |
| 2020 | Phase1/2a Clinical Trial of RPESC-derived RPE Transplantation as Therapy for Non-exudative Age-related Macular Degeneration1UG3EY031810-01 | STERN, JEFFREY H | REGENERATIVE RESEARCH FOUNDATION, NY | $200,571 | ZHL1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.